icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
BMS-986036, a PEGylated Fibroblast Growth Factor 21 Analogue for the Treatment of Non-Alcoholic Steatohepatitis: A Population Pharmacokinetics and Exposure-Response Analysis
 
 
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
 
Giridhar S. Tirucherai,1 Mats O. Magnusson,2 Chayan Acharya,2 Edgar Charles,1 Diane Shevell,1 Rose Christian,1 Yi Luo1
1Bristol-Myers Squibb, Princeton, New Jersey, USA; 2Pharmetheus AB, Uppsala, Sweden

AASDL1

AASDL2

AASDL3

AASDL4

AASDL5

AASDL6

AASDL7

AASDL8

AASDL9